INTERCEPT PHARMACEUTICALS, INC. Insider Trading for July 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for July 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 1,204 | 0 | 13,246 | 12 K to 13.2 K (+10.00 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Fundaro Paolo | Director | Grant | A | 0.00 | 1,204 | 0 | 10,075 | 8.9 K to 10.1 K (+13.57 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,204 | 0 | 2,504 | 1.3 K to 2.5 K (+92.62 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | SBLENDORIO GLENN | Director | Grant | A | 0.00 | 1,204 | 0 | 2,306 | 1.1 K to 2.3 K (+109.26 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Option Exercise | A | 145.22 | 1,598 | 232,062 | 1,598 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Benatti Luca | Director | Grant | A | 0.00 | 1,204 | 0 | 3,146 | 1.9 K to 3.1 K (+62.00 %) |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Option Exercise | A | 145.22 | 3,196 | 464,123 | 3,196 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | Gottesdiener Keith Michael | Director | Grant | A | 0.00 | 2,407 | 0 | 2,407 | 0 to 2.4 K |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Option Exercise | A | 145.22 | 3,196 | 464,123 | 3,196 | |
| Jul 21 2016 | ICPT | INTERCEPT PHARMACE ... | BRADBURY DANIEL | Director | Grant | A | 0.00 | 2,407 | 0 | 2,407 | 0 to 2.4 K |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 9.82 | 12,500 | 122,779 | 0 | |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Payment of Exercise | F | 148.73 | 7,341 | 1,091,827 | 552,725 | 560.1 K to 552.7 K (-1.31 %) |
| Jul 19 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 9.82 | 12,500 | 122,779 | 560,066 | 547.6 K to 560.1 K (+2.28 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Accounting Of ... | Sell | S | 145.11 | 146 | 21,186 | 30,808 | 31 K to 30.8 K (-0.47 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 145.11 | 163 | 23,653 | 48,391 | 48.6 K to 48.4 K (-0.34 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 145.11 | 714 | 103,608 | 547,566 | 548.3 K to 547.6 K (-0.13 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | McMinn Rachel | Chief Strategy Offi ... | Sell | S | 145.11 | 106 | 15,382 | 13,986 | 14.1 K to 14 K (-0.75 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | See Remarks | Sell | S | 145.11 | 155 | 22,492 | 18,706 | 18.9 K to 18.7 K (-0.82 %) |
| Jul 06 2016 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | Chief Financial Off ... | Option Exercise | A | 146.36 | 18,000 | 2,634,480 | 18,000 | |
| Jul 06 2016 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |